Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK

Biochemical and Biophysical Research Communications

Volumn 320, Issue 3, 2004, Pages 773-780

  Gurusamy, Narasimman ^a   Watanabe, Kenichi ^a   Ma, Meilei ^a   Zhang, Shaosong ^b   Muslin, Anthony J ^b   Kodama, Makoto ^c   Aizawa, Yoshifusa ^c  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN 14 3 3; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEART MUSCLE CELL; HEART WEIGHT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOLECULAR MECHANICS; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE; WESTERN BLOTTING;

14-3-3 PROTEINS; ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENZYME ACTIVATION; GENES, DOMINANT; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; MYOCYTES, CARDIAC; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; STREPTOZOCIN; TYROSINE 3-MONOOXYGENASE;

MUS MUSCULUS;

EID: 3042724643     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.06.023     Document Type: Article

References (48)

1. Fu H., Subramanium R.R., Masters S.C. 14-3-3 proteins structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40:2000;617-647
2. Muslin A.J., Xing H. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 12:2000;703-709
3. Fantl W.J., Muslin A.J., Kikuchi A., Martin J.A., MacNicol A.M., Gross R.W., Williams L.T. Activation of Raf-1 by 14-3-3 proteins. Nature. 371:1994;612-614
4. Robinson K., Jones D., Patel Y., Martin H., Madrazo J., Martin S., Howell S., Elmore M., Finnen M.J., Aitken A. Mechanism of inhibition of protein kinase C by 14-3-3 isoforms. 14-3-3 isoforms do not have phospholipase A2 activity. Biochem. J. 299:1994;853-861
5. Zhang L., Chen J., Fu H. Suppression of apoptosis signal regulating kinase I-induced cell death by 14-3-3 proteins. Proc. Natl. Acad. Sci. USA. 96:1999;8511-8515
6. Peng C.Y., Graves P.R., Thoma R.S., Wu Z., Shaw A.S., Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science. 277:1997;1501-1505
7. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X. Cell. 87:1999;619-628
8. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;857-868
9. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:1997;90-94
10. Xing H., Zhang S., Weinheimer C., Kovacs A., Muslin A.J. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 19:2000;349-358
11. Dorman J.S., Laporte R.E., Kuller L.H., Cruickshanks K.J., Orchard T.J., Wagener D.K., Becker D.J., Cavender D.E., Drash A.L. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 33:1984;271-276
12. Krolewski A.S., Warram J.H., Rand L.I., Kahn C.R. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N. Engl. J. Med. 317:1987;1390-1398
13. Fein F.S., Sonnenblick E.H. Diabetic cardiomyopathy. Prog. Cardiovasc. Dis. 27:1985;255-270
14. 2+ binding and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc. Natl. Acad. Sci. USA. 80:1983;5412-5416
15. +ATPase activity in diabetic rat heart. Am. J. Physiol. 245:1983;C241-C247
16. 2+ pump activity during diabetes mellitus. Am. J. Physiol. 252:1987;H540-H544
17. Malhotra A., Penpargkul S., Fein F.S., Sonnenblick E.H., Scheuer J. The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins. Circ. Res. 49:1981;1243-1250
18. Malhotra A., Reich D., Reich D., Nakouzi A., Sanghi V., Geenen D.L., Buttrick P.M. Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ. Res. 81:1997;1027-1033
19. Rodrigues B., Cam M.C., McNeill J.H. Metabolic disturbances in diabetic cardiomyopathy. Mol. Cell. Biochem. 180:1998;53-57
20. Hardin N.J. The myocardial and vascular pathology of diabetic cardiomyopathy. Coron. Artery Dis. 7:1996;99-108
21. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331
22. Ma X.L., Kumar S., Gao F., Louden C.S., Lopez B.L., Christopher T.A., Wang C., Lee J.C., Feuerstein G.Z., Yue T.L. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 99:1999;1685-1691
23. Cook S.A., Sugden P.H., Clerk A. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J. Mol. Cell. Cardiol. 31:1999;1429-1434
24. Haneda M., Araki S., Togawa M., Sugimoto T., Isono M., Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes. 46:1997;847-853
25. 2-terminal kinase and caspase-3. Circulation. 101:2000;2618-2624
26. Liu W., Schoenkerman A., Lowe W.L. Jr. Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 279:2000;E782-E790
27. Fernyhough P., Gallagher A., Averill S.A., Priestley J.V., Hounsom L., Patel J., Tomlinson D.R. Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes. 48:1999;881-889
28. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., Anversa P. Myocardial cell death in human diabetes. Circ. Res. 87:2000;1123-1132
29. Fiordaliso F., Li B., Latini R., Sonnenblick E.H., Anversa P., Leri A., Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab. Invest. 80:2000;513-527
30. Kajstura J., Fiordaliso F., Andreoli A.M., Li B., Chimenti S., Medow M.S., Limana F., Nadal-Ginard B., Leri A., Anversa P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes. 50:2001;1414-1424
31. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes. 51:2002;1938-1948
32. Subramaniam A., Jones W.K., Gulick J., Wert S., Neumann J., Robbins J. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266:1991;24613-24620
33. Rogers J.H., Tamirisa P., Kovacs A., Weinheimer C., Courtois M., Blumer K.J., Kelly D.P., Muslin A.J. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J. Clin. Invest. 104:1999;567-576
34. Komuro I., Kudo S., Yamazaki T., Zou Y., Shiojima I., Yazaki Y. Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes. FASEB J. 10:1996;631-636
35. 2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ. Res. 80:1997;139-146
36. Feuerstein G.Z., Young P.R. Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways. Cardiovasc. Res. 45:2000;560-569
37. Vogel W.H., Scholkens B.A., Sandow J., Muller G., Vogel W.F. Streptozotocin induced diabetes. Vogel G.H. Drug Discovery and Evaluation. second ed. 2002;951-952 Springer, Berlin
38. Aoki H., Kang P.M., Hampe J., Yoshimura K., Noma T., Matsuzaki M., Izumo S. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J. Biol. Chem. 277:2002;10244-10250
39. 2-terminal kinase-dependent activation of the mitochondrial pathway. Circ. Res. 92:2003;136-138
40. Chen Y.R., Wang X., Templeton D., Davis R.J., Tan T.H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:1996;31929-31936
41. 2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem. 272:1997;4631-4636
42. Cahill M.A., Peter M.E., Kischkel F.C., Chinnaiyan A.M., Dixit V.M., Krammer P.H., Nordheim A. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene. 13:1996;2087-2096
43. Strniskova M., Barancik M., Neckar J., Ravingerova T. Mitogen-activated protein kinases in the acute diabetic myocardium. Mol. Cell. Biochem. 249:2003;59-65
44. Kang S.W., Adler S.G., Lapage J., Natarajan R. p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli. Kidney Int. 60:2001;543-552
45. Dunlop M.E., Muggli E.E. Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney Int. 57:2000;464-475
46. Mackay K., Mochly-Rosen D. Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia. J. Mol. Cell. Cardiol. 32:2000;1585-1588
47. Communal C., Colucci W.S., Singh K. p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J. Biol. Chem. 275:2000;19395-19400
48. Zhang H., Shi X., Hampong M., Blanis L., Pelech S. Stress-induced inhibition of ERK1 and ERK2 by direct interaction with p38 MAP kinase. J. Biol. Chem. 276:2001;6905-6908